Medical Condition News

RSS

Illumina releases TruSight Tumor for NGS-based somatic variant detection in solid tumors

Illumina, Inc. today announced the next product in its TruSight line of content sets, TruSight Tumor, for NGS-based somatic variant detection in solid tumors.

From Illumina, Inc. 4 Apr 2013

Scientists develop new cancer immunotherapy treatment for children with high-risk solid tumors

Recently, research using adoptive T-cell immunotherapy in blood cancers have shown success, most notably in the case of a seven-year-old girl whose leukemia went into remission using altered T-cells and a disabled HIV virus.

4 Apr 2013

Weight loss and heart damage: an interview with Dr Lili Barouch, Johns Hopkins University School of Medicine

Obesity causes an increase in the stiffness of the heart, making it hard for the heart muscle to relax and fill with blood in between heartbeats. This abnormal stiffness can lead to congestive heart failure and other problems as it becomes more severe.

4 Apr 2013

Anthem Life Insurance supports Warfighter Sports program for fourth consecutive year

For the fourth year in a row, Anthem Life Insurance Company supports Disabled Sports USA's Warfighter Sports program to help severely injured service men and women rebuild their lives through sports with a ski event in the Tahoe ski area in Olympic Valley, California, from April 4 through April 6.

4 Apr 2013

Researchers use brain-imaging tool and stroke risk assessment to detect signs of cognitive decline

UCLA researchers have used a brain-imaging tool and stroke risk assessment to identify signs of cognitive decline early on in individuals who don't yet show symptoms of dementia.

4 Apr 2013

Integrated advanced cardiovascular imaging modalities can change cardiac care

Focusing on problem solving clinical approach, places the emphasis firmly on identifying the best test to answer each specific question in the most efficient way.

4 Apr 2013

Molecular diagnostic testing in lung cancer offers new hope for patients

The emergence of molecular diagnostic testing in lung cancer offers new hope for patients battling the number one cancer killer in the United States and abroad.

4 Apr 2013

Researchers predict probability of cardiovascular risk

Researchers at the Charité - Universitätsmedizin Berlin have managed to predict the probability of a cardiovascular patient suffering a heart attack, stroke or arterial occlusion within three months.

4 Apr 2013

Study explores views, beliefs about triggers of Meniere's disease symptoms

A report in one of the last issue of Psychotherapy and Psychosomatics addresses the physical and psychological triggers for attacks in Meniere's disease.

4 Apr 2013

Researchers identify vulnerability of lung-cancer cells that can be exploited for new therapies

Physician-researchers at UT Southwestern Medical Center have identified a vulnerability of certain lung-cancer cells - a specific genetic weakness that can be exploited for new therapies.

4 Apr 2013

Reuters examines implications of India's Novartis patent ruling for big pharma

Reuters examines the implications of India's Supreme Court ruling to reject drug maker Novartis's request for a new patent on an updated version of the cancer treatment Glivec on the pharmaceutical industry in India and across the developing world.

4 Apr 2013

Noven Pharmaceuticals files ANDA with FDA for approval of generic version of Exelon

Noven Pharmaceuticals, Inc. today confirmed that it has filed an Abbreviated New Drug Application with the U.S. Food and Drug Administration seeking approval to market its rivastigmine transdermal system in 4.6 mg/24 hours and 9.5 mg/24 hours dosage strengths.

4 Apr 2013

More must be done to find balance between drug innovation, affordable health care

"The decision by India's Supreme Court to overturn the patent on Novartis's cancer treatment Glivec is good news for more affordable health care and bad news for drug innovation," a Financial Times editorial states, adding, "It fails fundamentally to address either issue, both of which need wide-ranging reform.

4 Apr 2013

Despite discovery of sight-saving drugs, AMD still causes severe vision loss in older Americans

Age-related macular degeneration continues to be the leading cause of visual impairment in the United States for people over age 65, according to a study recently published online in Ophthalmology, the journal of the American Academy of Ophthalmology.

4 Apr 2013

Viewpoints: Obama's brain initiative is 'modest but welcome start;' Disability insurance facing 'immediate crisis'

President Obama officially announced his new brain research initiative on Tuesday, with a pledge to put $100 million in his 2014 budget to support work at three federal agencies.

4 Apr 2013

FDA clears ERYTECH Pharma' IND to start Phase I clinical trial of ERYASP in patients with ALL

ERYTECH Pharma SA announced today that it has received clearance of its Investigational New Drug Application from the United States Food and Drug Administration to initiate a Phase I clinical trial of its product ERYASP, L-asparaginase loaded erythrocytes, in patients 40 years or older with newly diagnosed Acute Lymphoblastic Leukemia.

4 Apr 2013

Clinical trial signals new era in treatment of neurodegererative disorders

The initial clinical trial of a novel approach to treating amyotrophic lateral sclerosis - blocking production of a mutant protein that causes an inherited form of the progressive neurodegererative disease - may be a first step towards a new era in the treatment of such disorders.

4 Apr 2013

Medical Condition News

Illumina releases TruSight Tumor for NGS-based somatic variant detection in solid tumors

Scientists develop new cancer immunotherapy treatment for children with high-risk solid tumors

Weight loss and heart damage: an interview with Dr Lili Barouch, Johns Hopkins University School of Medicine

Anthem Life Insurance supports Warfighter Sports program for fourth consecutive year

Researchers use brain-imaging tool and stroke risk assessment to detect signs of cognitive decline

Integrated advanced cardiovascular imaging modalities can change cardiac care

Molecular diagnostic testing in lung cancer offers new hope for patients

Researchers predict probability of cardiovascular risk

Study explores views, beliefs about triggers of Meniere's disease symptoms

Researchers identify vulnerability of lung-cancer cells that can be exploited for new therapies

Reuters examines implications of India's Novartis patent ruling for big pharma

Noven Pharmaceuticals files ANDA with FDA for approval of generic version of Exelon

More must be done to find balance between drug innovation, affordable health care

Despite discovery of sight-saving drugs, AMD still causes severe vision loss in older Americans

Viewpoints: Obama's brain initiative is 'modest but welcome start;' Disability insurance facing 'immediate crisis'

FDA clears ERYTECH Pharma' IND to start Phase I clinical trial of ERYASP in patients with ALL

Clinical trial signals new era in treatment of neurodegererative disorders

Obama rolls out $100M initiative to study the brain

Researchers confirm effectiveness of spray that improves dry mouth

Lund University researchers examine why people suffer vision loss in eye diseases

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Latest News